COVID-19 Impact on Global Immunotherapeutic Drugs Market Size, Status and Forecast 2020-2026
![](/report_cover/6975/covid-19-impact-on-global-immunotherapeutic-drugs-market-size-status-n-forecast-2020-2026_en.gif)
This report focuses on the global Immunotherapeutic Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immunotherapeutic Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
The key players covered in this study
- Roche
- Merck
- Novartis
- Johnson & Johnson
- GlaxoSmithKline
- AbbVie
- ELI Lilly
- Amgen
- AstraZeneca
- Bristol-Mysers Squibb
- Monoclonal Antibody
- Vaccines
- Checkpoint Inhibitor
- Interferon
- Hospitals
- Clinics
- Other
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global Immunotherapeutic Drugs status, future forecast, growth opportunity, key market and key players.
- To present the Immunotherapeutic Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Immunotherapeutic Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Immunotherapeutic Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monoclonal Antibody
1.4.3 Vaccines
1.4.4 Checkpoint Inhibitor
1.4.5 Interferon
1.5 Market by Application
1.5.1 Global Immunotherapeutic Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Immunotherapeutic Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Immunotherapeutic Drugs Industry
1.6.1.1 Immunotherapeutic Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Immunotherapeutic Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Immunotherapeutic Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Immunotherapeutic Drugs Market Perspective (2015-2026)
2.2 Immunotherapeutic Drugs Growth Trends by Regions
2.2.1 Immunotherapeutic Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Immunotherapeutic Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Immunotherapeutic Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Immunotherapeutic Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Immunotherapeutic Drugs Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Immunotherapeutic Drugs Players by Market Size
3.1.1 Global Top Immunotherapeutic Drugs Players by Revenue (2015-2020)
3.1.2 Global Immunotherapeutic Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Immunotherapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Immunotherapeutic Drugs Market Concentration Ratio
3.2.1 Global Immunotherapeutic Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Immunotherapeutic Drugs Revenue in 2019
3.3 Immunotherapeutic Drugs Key Players Head office and Area Served
3.4 Key Players Immunotherapeutic Drugs Product Solution and Service
3.5 Date of Enter into Immunotherapeutic Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Immunotherapeutic Drugs Historic Market Size by Type (2015-2020)
4.2 Global Immunotherapeutic Drugs Forecasted Market Size by Type (2021-2026)
5 IMMUNOTHERAPEUTIC DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Immunotherapeutic Drugs Market Size by Application (2015-2020)
5.2 Global Immunotherapeutic Drugs Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Immunotherapeutic Drugs Market Size (2015-2020)
6.2 Immunotherapeutic Drugs Key Players in North America (2019-2020)
6.3 North America Immunotherapeutic Drugs Market Size by Type (2015-2020)
6.4 North America Immunotherapeutic Drugs Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Immunotherapeutic Drugs Market Size (2015-2020)
7.2 Immunotherapeutic Drugs Key Players in Europe (2019-2020)
7.3 Europe Immunotherapeutic Drugs Market Size by Type (2015-2020)
7.4 Europe Immunotherapeutic Drugs Market Size by Application (2015-2020)
8 CHINA
8.1 China Immunotherapeutic Drugs Market Size (2015-2020)
8.2 Immunotherapeutic Drugs Key Players in China (2019-2020)
8.3 China Immunotherapeutic Drugs Market Size by Type (2015-2020)
8.4 China Immunotherapeutic Drugs Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Immunotherapeutic Drugs Market Size (2015-2020)
9.2 Immunotherapeutic Drugs Key Players in Japan (2019-2020)
9.3 Japan Immunotherapeutic Drugs Market Size by Type (2015-2020)
9.4 Japan Immunotherapeutic Drugs Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Immunotherapeutic Drugs Market Size (2015-2020)
10.2 Immunotherapeutic Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Immunotherapeutic Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Immunotherapeutic Drugs Market Size by Application (2015-2020)
11 INDIA
11.1 India Immunotherapeutic Drugs Market Size (2015-2020)
11.2 Immunotherapeutic Drugs Key Players in India (2019-2020)
11.3 India Immunotherapeutic Drugs Market Size by Type (2015-2020)
11.4 India Immunotherapeutic Drugs Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Immunotherapeutic Drugs Market Size (2015-2020)
12.2 Immunotherapeutic Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Immunotherapeutic Drugs Market Size by Type (2015-2020)
12.4 Central & South America Immunotherapeutic Drugs Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview and Its Total Revenue
13.1.3 Roche Immunotherapeutic Drugs Introduction
13.1.4 Roche Revenue in Immunotherapeutic Drugs Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview and Its Total Revenue
13.2.3 Merck Immunotherapeutic Drugs Introduction
13.2.4 Merck Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.2.5 Merck Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview and Its Total Revenue
13.3.3 Novartis Immunotherapeutic Drugs Introduction
13.3.4 Novartis Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview and Its Total Revenue
13.4.3 Johnson & Johnson Immunotherapeutic Drugs Introduction
13.4.4 Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Details
13.5.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.5.3 GlaxoSmithKline Immunotherapeutic Drugs Introduction
13.5.4 GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.5.5 GlaxoSmithKline Recent Development
13.6 AbbVie
13.6.1 AbbVie Company Details
13.6.2 AbbVie Business Overview and Its Total Revenue
13.6.3 AbbVie Immunotherapeutic Drugs Introduction
13.6.4 AbbVie Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.6.5 AbbVie Recent Development
13.7 ELI Lilly
13.7.1 ELI Lilly Company Details
13.7.2 ELI Lilly Business Overview and Its Total Revenue
13.7.3 ELI Lilly Immunotherapeutic Drugs Introduction
13.7.4 ELI Lilly Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.7.5 ELI Lilly Recent Development
13.8 Amgen
13.8.1 Amgen Company Details
13.8.2 Amgen Business Overview and Its Total Revenue
13.8.3 Amgen Immunotherapeutic Drugs Introduction
13.8.4 Amgen Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.8.5 Amgen Recent Development
13.9 AstraZeneca
13.9.1 AstraZeneca Company Details
13.9.2 AstraZeneca Business Overview and Its Total Revenue
13.9.3 AstraZeneca Immunotherapeutic Drugs Introduction
13.9.4 AstraZeneca Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.9.5 AstraZeneca Recent Development
13.10 Bristol-Mysers Squibb
13.10.1 Bristol-Mysers Squibb Company Details
13.10.2 Bristol-Mysers Squibb Business Overview and Its Total Revenue
13.10.3 Bristol-Mysers Squibb Immunotherapeutic Drugs Introduction
13.10.4 Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.10.5 Bristol-Mysers Squibb Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Immunotherapeutic Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Immunotherapeutic Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monoclonal Antibody
1.4.3 Vaccines
1.4.4 Checkpoint Inhibitor
1.4.5 Interferon
1.5 Market by Application
1.5.1 Global Immunotherapeutic Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Immunotherapeutic Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Immunotherapeutic Drugs Industry
1.6.1.1 Immunotherapeutic Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Immunotherapeutic Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Immunotherapeutic Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Immunotherapeutic Drugs Market Perspective (2015-2026)
2.2 Immunotherapeutic Drugs Growth Trends by Regions
2.2.1 Immunotherapeutic Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Immunotherapeutic Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Immunotherapeutic Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Immunotherapeutic Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Immunotherapeutic Drugs Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Immunotherapeutic Drugs Players by Market Size
3.1.1 Global Top Immunotherapeutic Drugs Players by Revenue (2015-2020)
3.1.2 Global Immunotherapeutic Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Immunotherapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Immunotherapeutic Drugs Market Concentration Ratio
3.2.1 Global Immunotherapeutic Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Immunotherapeutic Drugs Revenue in 2019
3.3 Immunotherapeutic Drugs Key Players Head office and Area Served
3.4 Key Players Immunotherapeutic Drugs Product Solution and Service
3.5 Date of Enter into Immunotherapeutic Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Immunotherapeutic Drugs Historic Market Size by Type (2015-2020)
4.2 Global Immunotherapeutic Drugs Forecasted Market Size by Type (2021-2026)
5 IMMUNOTHERAPEUTIC DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Immunotherapeutic Drugs Market Size by Application (2015-2020)
5.2 Global Immunotherapeutic Drugs Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Immunotherapeutic Drugs Market Size (2015-2020)
6.2 Immunotherapeutic Drugs Key Players in North America (2019-2020)
6.3 North America Immunotherapeutic Drugs Market Size by Type (2015-2020)
6.4 North America Immunotherapeutic Drugs Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Immunotherapeutic Drugs Market Size (2015-2020)
7.2 Immunotherapeutic Drugs Key Players in Europe (2019-2020)
7.3 Europe Immunotherapeutic Drugs Market Size by Type (2015-2020)
7.4 Europe Immunotherapeutic Drugs Market Size by Application (2015-2020)
8 CHINA
8.1 China Immunotherapeutic Drugs Market Size (2015-2020)
8.2 Immunotherapeutic Drugs Key Players in China (2019-2020)
8.3 China Immunotherapeutic Drugs Market Size by Type (2015-2020)
8.4 China Immunotherapeutic Drugs Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Immunotherapeutic Drugs Market Size (2015-2020)
9.2 Immunotherapeutic Drugs Key Players in Japan (2019-2020)
9.3 Japan Immunotherapeutic Drugs Market Size by Type (2015-2020)
9.4 Japan Immunotherapeutic Drugs Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Immunotherapeutic Drugs Market Size (2015-2020)
10.2 Immunotherapeutic Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Immunotherapeutic Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Immunotherapeutic Drugs Market Size by Application (2015-2020)
11 INDIA
11.1 India Immunotherapeutic Drugs Market Size (2015-2020)
11.2 Immunotherapeutic Drugs Key Players in India (2019-2020)
11.3 India Immunotherapeutic Drugs Market Size by Type (2015-2020)
11.4 India Immunotherapeutic Drugs Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Immunotherapeutic Drugs Market Size (2015-2020)
12.2 Immunotherapeutic Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Immunotherapeutic Drugs Market Size by Type (2015-2020)
12.4 Central & South America Immunotherapeutic Drugs Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview and Its Total Revenue
13.1.3 Roche Immunotherapeutic Drugs Introduction
13.1.4 Roche Revenue in Immunotherapeutic Drugs Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview and Its Total Revenue
13.2.3 Merck Immunotherapeutic Drugs Introduction
13.2.4 Merck Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.2.5 Merck Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview and Its Total Revenue
13.3.3 Novartis Immunotherapeutic Drugs Introduction
13.3.4 Novartis Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview and Its Total Revenue
13.4.3 Johnson & Johnson Immunotherapeutic Drugs Introduction
13.4.4 Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Details
13.5.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.5.3 GlaxoSmithKline Immunotherapeutic Drugs Introduction
13.5.4 GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.5.5 GlaxoSmithKline Recent Development
13.6 AbbVie
13.6.1 AbbVie Company Details
13.6.2 AbbVie Business Overview and Its Total Revenue
13.6.3 AbbVie Immunotherapeutic Drugs Introduction
13.6.4 AbbVie Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.6.5 AbbVie Recent Development
13.7 ELI Lilly
13.7.1 ELI Lilly Company Details
13.7.2 ELI Lilly Business Overview and Its Total Revenue
13.7.3 ELI Lilly Immunotherapeutic Drugs Introduction
13.7.4 ELI Lilly Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.7.5 ELI Lilly Recent Development
13.8 Amgen
13.8.1 Amgen Company Details
13.8.2 Amgen Business Overview and Its Total Revenue
13.8.3 Amgen Immunotherapeutic Drugs Introduction
13.8.4 Amgen Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.8.5 Amgen Recent Development
13.9 AstraZeneca
13.9.1 AstraZeneca Company Details
13.9.2 AstraZeneca Business Overview and Its Total Revenue
13.9.3 AstraZeneca Immunotherapeutic Drugs Introduction
13.9.4 AstraZeneca Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.9.5 AstraZeneca Recent Development
13.10 Bristol-Mysers Squibb
13.10.1 Bristol-Mysers Squibb Company Details
13.10.2 Bristol-Mysers Squibb Business Overview and Its Total Revenue
13.10.3 Bristol-Mysers Squibb Immunotherapeutic Drugs Introduction
13.10.4 Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2015-2020)
13.10.5 Bristol-Mysers Squibb Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Immunotherapeutic Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Immunotherapeutic Drugs Revenue
Table 3. Ranking of Global Top Immunotherapeutic Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Immunotherapeutic Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monoclonal Antibody
Table 6. Key Players of Vaccines
Table 7. Key Players of Checkpoint Inhibitor
Table 8. Key Players of Interferon
Table 9. COVID-19 Impact Global Market: (Four Immunotherapeutic Drugs Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Immunotherapeutic Drugs Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Immunotherapeutic Drugs Players to Combat Covid-19 Impact
Table 14. Global Immunotherapeutic Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Immunotherapeutic Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Immunotherapeutic Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Immunotherapeutic Drugs Market Share by Regions (2015-2020)
Table 18. Global Immunotherapeutic Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Immunotherapeutic Drugs Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Immunotherapeutic Drugs Market Growth Strategy
Table 24. Main Points Interviewed from Key Immunotherapeutic Drugs Players
Table 25. Global Immunotherapeutic Drugs Revenue by Players (2015-2020) (Million US$)
Table 26. Global Immunotherapeutic Drugs Market Share by Players (2015-2020)
Table 27. Global Top Immunotherapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunotherapeutic Drugs as of 2019)
Table 28. Global Immunotherapeutic Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Immunotherapeutic Drugs Product Solution and Service
Table 31. Date of Enter into Immunotherapeutic Drugs Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 34. Global Immunotherapeutic Drugs Market Size Share by Type (2015-2020)
Table 35. Global Immunotherapeutic Drugs Revenue Market Share by Type (2021-2026)
Table 36. Global Immunotherapeutic Drugs Market Size Share by Application (2015-2020)
Table 37. Global Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 38. Global Immunotherapeutic Drugs Market Size Share by Application (2021-2026)
Table 39. North America Key Players Immunotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Immunotherapeutic Drugs Market Share (2019-2020)
Table 41. North America Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 42. North America Immunotherapeutic Drugs Market Share by Type (2015-2020)
Table 43. North America Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 44. North America Immunotherapeutic Drugs Market Share by Application (2015-2020)
Table 45. Europe Key Players Immunotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Immunotherapeutic Drugs Market Share (2019-2020)
Table 47. Europe Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Immunotherapeutic Drugs Market Share by Type (2015-2020)
Table 49. Europe Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Immunotherapeutic Drugs Market Share by Application (2015-2020)
Table 51. China Key Players Immunotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 52. China Key Players Immunotherapeutic Drugs Market Share (2019-2020)
Table 53. China Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 54. China Immunotherapeutic Drugs Market Share by Type (2015-2020)
Table 55. China Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 56. China Immunotherapeutic Drugs Market Share by Application (2015-2020)
Table 57. Japan Key Players Immunotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Immunotherapeutic Drugs Market Share (2019-2020)
Table 59. Japan Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Immunotherapeutic Drugs Market Share by Type (2015-2020)
Table 61. Japan Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Immunotherapeutic Drugs Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Immunotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Immunotherapeutic Drugs Market Share (2019-2020)
Table 65. Southeast Asia Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Immunotherapeutic Drugs Market Share by Type (2015-2020)
Table 67. Southeast Asia Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Immunotherapeutic Drugs Market Share by Application (2015-2020)
Table 69. India Key Players Immunotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 70. India Key Players Immunotherapeutic Drugs Market Share (2019-2020)
Table 71. India Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 72. India Immunotherapeutic Drugs Market Share by Type (2015-2020)
Table 73. India Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 74. India Immunotherapeutic Drugs Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Immunotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Immunotherapeutic Drugs Market Share (2019-2020)
Table 77. Central & South America Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Immunotherapeutic Drugs Market Share by Type (2015-2020)
Table 79. Central & South America Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Immunotherapeutic Drugs Market Share by Application (2015-2020)
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Product
Table 84. Roche Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 85. Roche Recent Development
Table 86. Merck Company Details
Table 87. Merck Business Overview
Table 88. Merck Product
Table 89. Merck Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 90. Merck Recent Development
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis Product
Table 94. Novartis Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 95. Novartis Recent Development
Table 96. Johnson & Johnson Company Details
Table 97. Johnson & Johnson Business Overview
Table 98. Johnson & Johnson Product
Table 99. Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 100. Johnson & Johnson Recent Development
Table 101. GlaxoSmithKline Company Details
Table 102. GlaxoSmithKline Business Overview
Table 103. GlaxoSmithKline Product
Table 104. GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 105. GlaxoSmithKline Recent Development
Table 106. AbbVie Company Details
Table 107. AbbVie Business Overview
Table 108. AbbVie Product
Table 109. AbbVie Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 110. AbbVie Recent Development
Table 111. ELI Lilly Company Details
Table 112. ELI Lilly Business Overview
Table 113. ELI Lilly Product
Table 114. ELI Lilly Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 115. ELI Lilly Recent Development
Table 116. Amgen Business Overview
Table 117. Amgen Product
Table 118. Amgen Company Details
Table 119. Amgen Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 120. Amgen Recent Development
Table 121. AstraZeneca Company Details
Table 122. AstraZeneca Business Overview
Table 123. AstraZeneca Product
Table 124. AstraZeneca Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 125. AstraZeneca Recent Development
Table 126. Bristol-Mysers Squibb Company Details
Table 127. Bristol-Mysers Squibb Business Overview
Table 128. Bristol-Mysers Squibb Product
Table 129. Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 130. Bristol-Mysers Squibb Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 1. Immunotherapeutic Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Immunotherapeutic Drugs Revenue
Table 3. Ranking of Global Top Immunotherapeutic Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Immunotherapeutic Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monoclonal Antibody
Table 6. Key Players of Vaccines
Table 7. Key Players of Checkpoint Inhibitor
Table 8. Key Players of Interferon
Table 9. COVID-19 Impact Global Market: (Four Immunotherapeutic Drugs Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Immunotherapeutic Drugs Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Immunotherapeutic Drugs Players to Combat Covid-19 Impact
Table 14. Global Immunotherapeutic Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Immunotherapeutic Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Immunotherapeutic Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Immunotherapeutic Drugs Market Share by Regions (2015-2020)
Table 18. Global Immunotherapeutic Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Immunotherapeutic Drugs Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Immunotherapeutic Drugs Market Growth Strategy
Table 24. Main Points Interviewed from Key Immunotherapeutic Drugs Players
Table 25. Global Immunotherapeutic Drugs Revenue by Players (2015-2020) (Million US$)
Table 26. Global Immunotherapeutic Drugs Market Share by Players (2015-2020)
Table 27. Global Top Immunotherapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunotherapeutic Drugs as of 2019)
Table 28. Global Immunotherapeutic Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Immunotherapeutic Drugs Product Solution and Service
Table 31. Date of Enter into Immunotherapeutic Drugs Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 34. Global Immunotherapeutic Drugs Market Size Share by Type (2015-2020)
Table 35. Global Immunotherapeutic Drugs Revenue Market Share by Type (2021-2026)
Table 36. Global Immunotherapeutic Drugs Market Size Share by Application (2015-2020)
Table 37. Global Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 38. Global Immunotherapeutic Drugs Market Size Share by Application (2021-2026)
Table 39. North America Key Players Immunotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Immunotherapeutic Drugs Market Share (2019-2020)
Table 41. North America Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 42. North America Immunotherapeutic Drugs Market Share by Type (2015-2020)
Table 43. North America Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 44. North America Immunotherapeutic Drugs Market Share by Application (2015-2020)
Table 45. Europe Key Players Immunotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Immunotherapeutic Drugs Market Share (2019-2020)
Table 47. Europe Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Immunotherapeutic Drugs Market Share by Type (2015-2020)
Table 49. Europe Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Immunotherapeutic Drugs Market Share by Application (2015-2020)
Table 51. China Key Players Immunotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 52. China Key Players Immunotherapeutic Drugs Market Share (2019-2020)
Table 53. China Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 54. China Immunotherapeutic Drugs Market Share by Type (2015-2020)
Table 55. China Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 56. China Immunotherapeutic Drugs Market Share by Application (2015-2020)
Table 57. Japan Key Players Immunotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Immunotherapeutic Drugs Market Share (2019-2020)
Table 59. Japan Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Immunotherapeutic Drugs Market Share by Type (2015-2020)
Table 61. Japan Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Immunotherapeutic Drugs Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Immunotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Immunotherapeutic Drugs Market Share (2019-2020)
Table 65. Southeast Asia Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Immunotherapeutic Drugs Market Share by Type (2015-2020)
Table 67. Southeast Asia Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Immunotherapeutic Drugs Market Share by Application (2015-2020)
Table 69. India Key Players Immunotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 70. India Key Players Immunotherapeutic Drugs Market Share (2019-2020)
Table 71. India Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 72. India Immunotherapeutic Drugs Market Share by Type (2015-2020)
Table 73. India Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 74. India Immunotherapeutic Drugs Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Immunotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Immunotherapeutic Drugs Market Share (2019-2020)
Table 77. Central & South America Immunotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Immunotherapeutic Drugs Market Share by Type (2015-2020)
Table 79. Central & South America Immunotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Immunotherapeutic Drugs Market Share by Application (2015-2020)
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Product
Table 84. Roche Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 85. Roche Recent Development
Table 86. Merck Company Details
Table 87. Merck Business Overview
Table 88. Merck Product
Table 89. Merck Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 90. Merck Recent Development
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis Product
Table 94. Novartis Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 95. Novartis Recent Development
Table 96. Johnson & Johnson Company Details
Table 97. Johnson & Johnson Business Overview
Table 98. Johnson & Johnson Product
Table 99. Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 100. Johnson & Johnson Recent Development
Table 101. GlaxoSmithKline Company Details
Table 102. GlaxoSmithKline Business Overview
Table 103. GlaxoSmithKline Product
Table 104. GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 105. GlaxoSmithKline Recent Development
Table 106. AbbVie Company Details
Table 107. AbbVie Business Overview
Table 108. AbbVie Product
Table 109. AbbVie Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 110. AbbVie Recent Development
Table 111. ELI Lilly Company Details
Table 112. ELI Lilly Business Overview
Table 113. ELI Lilly Product
Table 114. ELI Lilly Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 115. ELI Lilly Recent Development
Table 116. Amgen Business Overview
Table 117. Amgen Product
Table 118. Amgen Company Details
Table 119. Amgen Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 120. Amgen Recent Development
Table 121. AstraZeneca Company Details
Table 122. AstraZeneca Business Overview
Table 123. AstraZeneca Product
Table 124. AstraZeneca Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 125. AstraZeneca Recent Development
Table 126. Bristol-Mysers Squibb Company Details
Table 127. Bristol-Mysers Squibb Business Overview
Table 128. Bristol-Mysers Squibb Product
Table 129. Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2015-2020) (Million US$)
Table 130. Bristol-Mysers Squibb Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Immunotherapeutic Drugs Market Share by Type: 2020 VS 2026
Figure 2. Monoclonal Antibody Features
Figure 3. Vaccines Features
Figure 4. Checkpoint Inhibitor Features
Figure 5. Interferon Features
Figure 6. Global Immunotherapeutic Drugs Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Other Case Studies
Figure 10. Immunotherapeutic Drugs Report Years Considered
Figure 11. Global Immunotherapeutic Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Immunotherapeutic Drugs Market Share by Regions: 2020 VS 2026
Figure 13. Global Immunotherapeutic Drugs Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Immunotherapeutic Drugs Market Share by Players in 2019
Figure 16. Global Top Immunotherapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunotherapeutic Drugs as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Immunotherapeutic Drugs Revenue in 2019
Figure 18. North America Immunotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Immunotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Immunotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Immunotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Immunotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Immunotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Immunotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Roche Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 27. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Merck Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 29. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Novartis Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 31. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Johnson & Johnson Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 33. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. GlaxoSmithKline Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 35. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. AbbVie Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 37. ELI Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. ELI Lilly Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 39. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Amgen Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 41. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. AstraZeneca Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 43. Bristol-Mysers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Bristol-Mysers Squibb Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Figure 1. Global Immunotherapeutic Drugs Market Share by Type: 2020 VS 2026
Figure 2. Monoclonal Antibody Features
Figure 3. Vaccines Features
Figure 4. Checkpoint Inhibitor Features
Figure 5. Interferon Features
Figure 6. Global Immunotherapeutic Drugs Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Other Case Studies
Figure 10. Immunotherapeutic Drugs Report Years Considered
Figure 11. Global Immunotherapeutic Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Immunotherapeutic Drugs Market Share by Regions: 2020 VS 2026
Figure 13. Global Immunotherapeutic Drugs Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Immunotherapeutic Drugs Market Share by Players in 2019
Figure 16. Global Top Immunotherapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunotherapeutic Drugs as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Immunotherapeutic Drugs Revenue in 2019
Figure 18. North America Immunotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Immunotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Immunotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Immunotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Immunotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Immunotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Immunotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Roche Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 27. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Merck Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 29. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Novartis Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 31. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Johnson & Johnson Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 33. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. GlaxoSmithKline Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 35. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. AbbVie Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 37. ELI Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. ELI Lilly Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 39. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Amgen Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 41. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. AstraZeneca Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 43. Bristol-Mysers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Bristol-Mysers Squibb Revenue Growth Rate in Immunotherapeutic Drugs Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed